|
|
|
|
||
Re: NORTH..rufustoo many are over looking value proposition emerging from Navidea science of Blocking of SIRPα/CD47 in TAMS and others identifying opportunities in lungs, intracerebral hemorrhage and expanding, by M1/M2 reprogramming, with ongoing IP filings and MG settlement opportunity |
return to message board, top of board |
Msg # | Subject | Author | Recs | Date Posted |
38620 | Re: NORTH..rufus | LVoptimist | 1 | 12/2/2022 2:59:49 PM |